Literature DB >> 18437565

The abnormally phosphorylated tau lesion of early Alzheimer's disease.

Ramasamy Thangavel1, Gary W Van Hoesen, Asgar Zaheer.   

Abstract

The perirhinal cortex (area 35) is well-known locus for neurofibrillary tangles (NFT) in initial Alzheimer's disease (AD) and fully developed AD and may contain tau alterations in non-demented elderly. The topography and location of this vulnerable cortex, however, is difficult to appreciate because of its variable architecture and to deviations imposed by temporal sulcal patterns. We have immunostained human brains with a short duration of dementia using antibody AT8, which recognize abnormally hyperphosphorylated tau, calcium binding protein-parvalbumin and other phenotype markers to more fully appreciate the extent of area 35 before it is obscured by pathology. We have observed in the mildly affected AD tau immunoreactive lesion that extends from the temporopolar/insular region anteriorly to the posterior parahippocampal cortex. In its anterior-posterior course, it covers the medial bank of the collateral sulcus. Although the tau lesion encroaches slightly into the temporopolar cortex (area TG) anteriorly and medially and the ectorhinal cortex (area 36) laterally, area 35 is unambiguously defined. Ventromedial temporal pathology as revealed by AT8 suggests the presence of a relatively large lesion early in AD involving all of the perirhinal cortex and other non-isocortical areas. The present study demonstrated that the early stage AD patients exhibited AT8 immunoreactive cells in the temporopolar, hippocampus, perirhinal, entorhinal, and insular cortices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437565     DOI: 10.1007/s11064-008-9701-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease.

Authors:  G W Van Hoesen; A Solodkin
Journal:  Cereb Cortex       Date:  1993 Sep-Oct       Impact factor: 5.357

2.  Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease.

Authors:  H J Gertz; J Xuereb; F Huppert; C Brayne; M A McGee; E Paykel; C Harrington; E Mukaetova-Ladinska; T Arendt; C M Wischik
Journal:  Acta Neuropathol       Date:  1998-02       Impact factor: 17.088

Review 3.  Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease.

Authors:  P R Hof
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

Review 4.  Neurodegenerative disorders with extensive tau pathology: a comparative study and review.

Authors:  M B Feany; D W Dickson
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

5.  Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders.

Authors:  W Härtig; C Klein; K Brauer; K F Schüppel; T Arendt; G Brückner; V Bigl
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

6.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Phosphorylation of tau by fyn: implications for Alzheimer's disease.

Authors:  Gloria Lee; Ramasamy Thangavel; Vandana M Sharma; Joel M Litersky; Kiran Bhaskar; Sandy M Fang; Lana H Do; Athena Andreadis; Gary Van Hoesen; Hanna Ksiezak-Reding
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  13 in total

1.  Augmented expression of glia maturation factor in Alzheimer's disease.

Authors:  S Zaheer; R Thangavel; S K Sahu; A Zaheer
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

2.  Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Ramasamy Thangavel; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-03-25       Impact factor: 3.996

3.  Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Marina Weiler; Camila Vieira Ligo Teixeira; Mateus Henrique Nogueira; Brunno Machado de Campos; Benito Pereira Damasceno; Fernando Cendes; Marcio Luiz Figueredo Balthazar
Journal:  Brain Connect       Date:  2014-09-19

4.  Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Authors:  R Thangavel; D Stolmeier; X Yang; P Anantharam; A Zaheer
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

5.  Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.

Authors:  Shannon N Campbell; Cheng Zhang; Allyson D Roe; Nickey Lee; Kathleen U Lao; Louise Monte; Michael C Donohue; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Marcus Ahrens; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Int       Date:  2011-12-30       Impact factor: 3.921

7.  Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.

Authors:  Smita Zaheer; Yanghong Wu; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurobiol Dis       Date:  2010-08-07       Impact factor: 5.996

8.  Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain.

Authors:  Ramasamy Thangavel; Duraisamy Kempuraj; Deirdre Stolmeier; Poojya Anantharam; Mohammad Khan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-29       Impact factor: 3.996

9.  Glia maturation factor expression in hippocampus of human Alzheimer's disease.

Authors:  Deirdre Stolmeier; Ramasamy Thangavel; Poojya Anantharam; Mohammad M Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-03       Impact factor: 3.996

10.  Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice.

Authors:  Smita Zaheer; Ramasamy Thangavel; Yanghong Wu; Mohammad Moshahid Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-10-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.